Back to top

Top Ranked Value Stocks to Buy for February 13th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, February 13th:

Jabil Inc. (JBL - Free Report) : This electronic manufacturing services and solutions provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1% over the last 60 days.

Jabil, Inc. Price and Consensus

Jabil, Inc. Price and Consensus

Jabil, Inc. price-consensus-chart | Jabil, Inc. Quote

Jabil has a price-to-earnings ratio (P/E) of 9.34, compared with 17.90 for the industry. The company possesses a Value Score of B.

Jabil, Inc. PE Ratio (TTM)

Jabil, Inc. PE Ratio (TTM)

Jabil, Inc. pe-ratio-ttm | Jabil, Inc. Quote

LexinFintech Holdings Ltd. (LX - Free Report) : This online consumer finance platform has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.

LexinFintech has a price-to-earnings ratio (P/E) of 7.09, compared with 8.40 for the industry. The company possesses a Value Score of B.

Ardagh Group S.A. (ARD - Free Report) : This rigid packaging solutions manufacturer for the food and beverage markets has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.6% over the last 60 days.

Ardagh has a price-to-earnings ratio (P/E) of 7.10, compared with 17.20 for the industry. The company possesses a Value Score of A.

SkyWest, Inc. (SKYW): This regional airline has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 5.3% over the last 60 days.

SkyWest has a price-to-earnings ratio (P/E) of 9.48, compared with 14.20 for the industry. The company possesses a Value Scoreof A.

SkyWest, Inc. PE Ratio (TTM)

SkyWest, Inc. PE Ratio (TTM)

SkyWest, Inc. pe-ratio-ttm | SkyWest, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



More from Zacks Zacks #1 Rank Additions

You May Like